Capital Flow Monitor · Sponsors · CIK 2022524
ReEngage Therapeutics, Inc.
2450 HOLCOMBE BLVD. SUITE 1200, HOUSTON, TX, 77021 · 215-400-0133
Other Health Care · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$8.0M
Sold
$365K
% sold
4.6%
Investors
6
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-01 | D/A ·current | 506(b) | $8.0M | $365K | 4.6% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Thomas Kim — Executive Officer / Director, Houston, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.